What is Small Pharma Inc. (DMTTF)?

Small Pharma Inc. (DMTTF) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of DMTTF?

The current price of DMTTF is $0.11. Prices are updated in real time on Stocks360.

What is DMTTF's price-to-earnings (PE) ratio?

DMTTF's trailing twelve-month PE ratio is -2.20, based on current price and earnings per share data available on Stocks360.

What is DMTTF's market capitalization?

DMTTF's market capitalization is $37,505,507.00, placing it in the small-cap tier.

Small Pharma Inc. (DMTTF)

Stock analysis · OTC · Healthcare · Biotechnology

$0.11

Market Cap

$37.51M

PE (TTM)

-2.20

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.85

Day Range

$0.11 – $0.13

52-wk Range

$0.05 – $0.19

Avg Volume

N/A

Volume

108.70K

Small Pharma Inc. (DMTTF) is a publicly traded company in the Healthcare sector. Latest price: $0.11. Market cap $37.51M. Trailing PE -2.20. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Jan 25, 2023

EPS $-0.02 vs est. $-0.02

Beat by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About Small Pharma Inc.

Small Pharma Inc. is a biotechnology firm focused on developing fast-acting psychedelic therapies, coupled with supportive psychological care, to address mental health conditions. Its flagship clinical initiative centers on N,N-dimethyltryptamine (DMT) assisted therapy designed to combat major depressive disorder. Specifically, its compound SPL026 is currently in Phase IIA clinical trials for MDD treatment. The company's preclinical pipeline also includes SPL028, a prolonged DMT series; SPL029, an oral DMT series; and SPL801, an oral formulation of 6-hydroxynorketamine. Founded in 2015, Small Pharma Inc. is headquartered in London, United Kingdom.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-2.20×
P/S (TTM)	0.00×
P/B	2.92×
PEG	0.15×
P/FCF (TTM)	-2.35×
EV / EBITDA	-1.40×
EV / Sales	0.00×
Earnings Yield	-45.55%
Free Cash Flow Yield	-42.47%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$34.44M
Net Income (TTM)	-$23.85M
Free Cash Flow (TTM)	-$22.24M
Net Debt	-$17.93M
Working Capital	$16.80M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	-78.43%
Return on Invested Capital	-128.32%